lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate

C42H27LiN3O+ — CID 140600453

IUPAClithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate
SMILES[Li+].[O-]c1c(-c2cccc3cc4c(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)cc5)cccc4cc23)ccc2ccc[nH+]c12
InChIInChI=1S/C42H27N3O.Li/c46-41-35(23-22-28-11-8-24-43-40(28)41)34-15-7-10-31-25-36-30(26-37(31)34)9-6-14-33(36)27-18-20-29(21-19-27)42-44-38-16-4-5-17-39(38)45(42)32-12-2-1-3-13-32;/h1-26,46H;/q;+1
InChIKeyBGZRPGKHFGHJMK-UHFFFAOYSA-N
MW596.64 g/mol
LogP6.38
Rot. Bonds4

About lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate

lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate (PubChem CID 140600453) has the molecular formula C42H27LiN3O+ and a molecular weight of 596.64 g/mol. Its IUPAC name is lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate.

Molecular Properties

Compound Namelithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate
PubChem CID140600453
Molecular FormulaC42H27LiN3O+
Molecular Weight596.64 g/mol
Exact Mass596.23
IUPAC Namelithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate
SMILES[Li+].[O-]c1c(-c2cccc3cc4c(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)cc5)cccc4cc23)ccc2ccc[nH+]c12
InChIInChI=1S/C42H27N3O.Li/c46-41-35(23-22-28-11-8-24-43-40(28)41)34-15-7-10-31-25-36-30(26-37(31)34)9-6-14-33(36)27-18-20-29(21-19-27)42-44-38-16-4-5-17-39(38)45(42)32-12-2-1-3-13-32;/h1-26,46H;/q;+1
InChIKeyBGZRPGKHFGHJMK-UHFFFAOYSA-N
XLogP6.38
TPSA55.02 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms47
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500596.64
LogP ≤ 56.38
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-(1H-benzimidazol-2-ylmethyl)-3-[(4-fluorophenyl)methyl]-7-methylpyrrolo[3,4-g]quinoline-8,9-diol
CID 91170969
3-[7-[3-(8-fluoroquinolin-2-yl)indol-1-yl]-1H-benzimidazol-2-yl]naphthalen-2-ol
CID 144941124
10-acridin-9-ylanthracen-9-ol;1H-imidazole
CID 168327448
7-[4-[3-Tert-butyl-5-(4-phenyl-2-pyridinyl)phenyl]-1-[2,6-di(propan-2-yl)phenyl]-6-(2,2,2-trifluoroethyl)benzimidazol-2-yl]quinolin-8-ol
CID 177293742
Beryllium bis(2-(3-methylbenzo[e]benzimidazol-1-ium-2-yl)naphthalen-1-olate)
CID 57621813
Beryllium;benzo[h]quinolin-1-ium-10-olate;2-(1-phenylbenzimidazol-3-ium-2-yl)phenolate
CID 57735208
Beryllium;benzo[h]quinolin-1-ium-10-olate;2-(1-phenylbenzimidazol-3-ium-2-yl)phenol;hydroxide
CID 57903534
11-[2-(1H-benzimidazol-2-yl)phenoxy]-10,12-dioxa-3-aza-11-indatetracyclo[11.8.0.04,9.016,21]henicosa-1(13),2,4,6,8,14,16,18,20-nonaene
CID 58886970
Beryllium;5,6-dihydrobenzo[h]quinolin-1-ium-10-olate;2-(1-phenylbenzimidazol-3-ium-2-yl)phenolate
CID 59236266
8-(tert-Butyldimethylsilanyloxy)-5-[4-(1-phenyl-1H-benzimidazol-2-yl)phenyl]quinoline
CID 67362201
2-[[1-[2-[(8-hydroxyquinolin-2-yl)methylamino]ethyl]benzimidazol-2-yl]methyl]-3H-benzimidazole-5-carboximidamide
CID 70138730
5-[3-(1-Phenylbenzimidazol-2-yl)phenyl]quinolin-8-ol
CID 71036736

Frequently Asked Questions

What is the IUPAC name of lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate?
The IUPAC name of lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate (CID 140600453) is lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate.
What is the SMILES notation for lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate?
The canonical SMILES for lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate is [Li+].[O-]c1c(-c2cccc3cc4c(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)cc5)cccc4cc23)ccc2ccc[nH+]c12.
What is the InChIKey of lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate?
The InChIKey is BGZRPGKHFGHJMK-UHFFFAOYSA-N. The full InChI is InChI=1S/C42H27N3O.Li/c46-41-35(23-22-28-11-8-24-43-40(28)41)34-15-7-10-31-25-36-30(26-37(31)34)9-6-14-33(36)27-18-20-29(21-19-27)42-44-38-16-4-5-17-39(38)45(42)32-12-2-1-3-13-32;/h1-26,46H;/q;+1.
What are the key properties of lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate?
lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate has a molecular weight of 596.64 g/mol, XLogP of 6.38, 4 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for lithium 7-[5-[4-(1-phenylbenzimidazol-2-yl)phenyl]anthracen-1-yl]quinolin-1-ium-8-olate is sourced from PubChem (CID 140600453), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).